Virtu KCG Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Virtu KCG Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$124K	Buy	+14,061	New	+$90.2K	﹤0.01%	2357
2016 Q4	–	Sell	-31,653	Closed	-$147K	–	3761
2016 Q3	$147K	Buy	+31,653	New	+$161K	﹤0.01%	2506
2016 Q2	–	Sell	-33,810	Closed	-$205K	–	3299
2016 Q1	$205K	Buy	33,810 +15,071	+80%	+$90.5K	0.01%	2082
2015 Q4	$171K	Sell	18,739 -10,852	-37%	-$83.6K	﹤0.01%	2796
2015 Q3	$167K	Buy	+29,591	New	+$244K	﹤0.01%	2645
2015 Q2	–	Sell	-11,123	Closed	-$174K	–	3703
2015 Q1	$174K	Buy	+11,123	New	+$172K	﹤0.01%	2465
2014 Q4	–	Sell	-28,302	Closed	-$305K	–	4195
2014 Q3	$305K	Buy	28,302 +13,766	+95%	+$180K	0.01%	2347
2014 Q2	$222K	Sell	14,536 -21,816	-60%	-$314K	﹤0.01%	2940
2014 Q1	$657K	Buy	+36,352	New	+$701K	0.01%	1648

Other funds holding SGMO

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Virtu KCG Holdings's SGMO Position: Q2 2017 in Review

Virtu KCG Holdings opened a new position in SANGAMO THERAPEUTICS INC (SGMO) in Q2 2017: 14,061 shares worth $124K. The stake represents ﹤0.01% of the portfolio and ranks #2357 among its holdings. This is a return to the name: Virtu KCG Holdings previously reported a position in SGMO as recently as Q3 2016.

Virtu KCG Holdings first reported a position in SGMO in Q1 2014 and has held it in 9 quarters since. The position peaked at $657K in Q1 2014. 143 funds tracked by Wall St. Rank hold SGMO as of Q2 2017.

Virtu KCG Holdings held 14,061 shares of SANGAMO THERAPEUTICS INC worth $124K as of Q2 2017.
SANGAMO THERAPEUTICS INC was a new Virtu KCG Holdings position in Q2 2017.
SANGAMO THERAPEUTICS INC made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2357 holding.
Virtu KCG Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q1 2014 and has held it in 9 quarters since.
Virtu KCG Holdings's SANGAMO THERAPEUTICS INC position peaked at $657K in Q1 2014.
143 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.